Smoking Cessation
Conditions
Brief summary
The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit. The main questions it aims to answer are: * Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation? * Will those in the intervention group be more likely to report smoking cessation than those in the control group. Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey. Participants in the control group will be asked to complete a baseline survey and an exit survey.
Interventions
BEHAVIORALPharmacist Intervention
If the patient is randomized to the intervention group, they will complete a series of phone calls with the research pharmacist. These will occur at baseline (within 1 to 2 days of enrollment), 2-weeks, 4-weeks, 6-weeks, 8-weeks, 10-weeks, and 12-weeks. During these calls, the research pharmacist will ask the patient about any past quit attempts; when they had their last cigarette; if they have been prescribed any cessation medications; if they have picked up their medication; if they have started the medication; they will assess their stage of change for quitting; discuss pros, cons, and barriers of quitting; behavioral responses to triggers/urges; and make any necessary nicotine replacement therapy (NRT; i.e., nicotine patches, gums, lozenges, inhalers, and/or nasal sprays) changes. Each call is expected to take 20-30 minutes.
Sponsors
University of Iowa
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Current smoker * Current patient in the Lung Cancer Screening Program
Exclusion criteria
* Unable to speak/read English * Unable to provide their own written informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Interactions With Pharmacist | 12 weeks | The number of phone calls the intervention participants complete with the research pharmacist. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Nicotine Replacement Therapies Used to Quit Smoking | 12 weeks | The number of participants who use nicotine replacement therapies during the study. |
| Number of Non-Medication Tools Used to Quit Smoking | 12 weeks | The number of participants who use non-medication tools to quit smoking. |
| Number of Successful Quit Attempts | 12 weeks | The number of participants who have successfully quit smoking at the end of the study. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORJacob E Simmering, PhD
University of Iowa
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 63.3 Years STANDARD_DEVIATION 6.1 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 35 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 9 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 2 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 4 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 2 Participants |
| Race (NIH/OMB) White | 34 Participants |
| Region of Enrollment United States | 38 Participants |
| Sex: Female, Male Female | 28 Participants |
| Sex: Female, Male Male | 13 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 42 | 0 / 38 |
| other Total, other adverse events | 0 / 42 | 0 / 38 |
| serious Total, serious adverse events | 0 / 42 | 0 / 38 |
Outcome results
None listed